Current and historical daily PE Ratio for Zydus Lifesciences Ltd (
) from 2000 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zydus Lifesciences stock (BOM:532321) PE ratio as of May 27 2024 is 28.21.
More Details
Zydus Lifesciences Ltd (BOM:532321) PE Ratio (TTM) Chart
Zydus Lifesciences Ltd (BOM:532321) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Zydus Lifesciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-27 | 28.2 | 2024-03-14 | 33.9 |
| 2024-05-24 | 28.2 | 2024-03-13 | 33.0 |
| 2024-05-23 | 28.5 | 2024-03-12 | 33.6 |
| 2024-05-22 | 28.2 | 2024-03-11 | 33.8 |
| 2024-05-21 | 28.5 | 2024-03-07 | 33.2 |
| 2024-05-17 | 27.6 | 2024-03-06 | 32.7 |
| 2024-05-16 | 26.4 | 2024-03-05 | 32.5 |
| 2024-05-15 | 26.1 | 2024-03-04 | 32.2 |
| 2024-05-14 | 25.8 | 2024-03-01 | 31.5 |
| 2024-05-13 | 26.0 | 2024-02-29 | 32.1 |
| 2024-05-10 | 25.8 | 2024-02-28 | 31.7 |
| 2024-05-09 | 25.4 | 2024-02-27 | 32.1 |
| 2024-05-08 | 26.4 | 2024-02-26 | 32.1 |
| 2024-05-07 | 25.7 | 2024-02-23 | 31.4 |
| 2024-05-06 | 26.8 | 2024-02-22 | 30.8 |
| 2024-05-03 | 26.1 | 2024-02-21 | 30.4 |
| 2024-05-02 | 25.9 | 2024-02-20 | 30.5 |
| 2024-04-30 | 25.0 | 2024-02-19 | 30.9 |
| 2024-04-29 | 25.3 | 2024-02-16 | 30.3 |
| 2024-04-26 | 24.9 | 2024-02-15 | 29.9 |
| 2024-04-25 | 24.9 | 2024-02-14 | 29.5 |
| 2024-04-24 | 24.5 | 2024-02-13 | 29.2 |
| 2024-04-23 | 25.2 | 2024-02-12 | 29.1 |
| 2024-04-22 | 25.2 | 2024-02-09 | 27.4 |
| 2024-04-19 | 24.2 | 2024-02-08 | 27.3 |
| 2024-04-18 | 24.6 | 2024-02-07 | 26.9 |
| 2024-04-16 | 24.8 | 2024-02-06 | 27.1 |
| 2024-04-15 | 24.5 | 2024-02-05 | 25.9 |
| 2024-04-12 | 25.2 | 2024-02-02 | 25.9 |
| 2024-04-10 | 26.1 | 2024-02-01 | 25.9 |
| 2024-04-09 | 25.9 | 2024-01-31 | 25.9 |
| 2024-04-08 | 26.2 | 2024-01-30 | 25.7 |
| 2024-04-05 | 26.4 | 2024-01-29 | 25.5 |
| 2024-04-04 | 25.8 | 2024-01-25 | 25.1 |
| 2024-04-03 | 25.9 | 2024-01-24 | 25.6 |
| 2024-04-02 | 26.0 | 2024-01-23 | 24.8 |
| 2024-04-01 | 26.2 | 2024-01-19 | 24.5 |
| 2024-03-28 | 26.4 | 2024-01-18 | 24.1 |
| 2024-03-27 | 34.0 | 2024-01-17 | 24.1 |
| 2024-03-26 | 34.6 | 2024-01-16 | 24.0 |
| 2024-03-22 | 34.0 | 2024-01-15 | 24.4 |
| 2024-03-21 | 33.7 | 2024-01-12 | 23.9 |
| 2024-03-20 | 33.0 | 2024-01-11 | 24.0 |
| 2024-03-19 | 33.0 | 2024-01-10 | 24.0 |
| 2024-03-18 | 33.7 | 2024-01-09 | 24.3 |
Zydus Lifesciences Ltd (BOM:532321) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Zydus Lifesciences Ltd
ISIN : INE010B01027
Share Class Description:
BOM:532321: Ordinary SharesCompare
Compare
Traded in other countries / regions
ZYDUSLIFE.India IPO Date
2000-04-18Description
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers